Comera SPAC Presentation Deck

SQore™ Well-Positioned vs. Other Approaches Large market opportunity accommodates multiple players Viscosity Reducing Technology Enzyme Based Technology Oral Delivery Comera LIFE SCIENCES Excelse Bio Lindy Biosciences Arecor ARSIA THERAPEUTICS EAGLE PHARMACEUTICALS Halozyme ALTEOGEN Inc. Rani THERAPEUTICS Comera LIFE SCIENCES Score: scientifically validated, well-characterized excipient technology, all previously used in humans, allowing for low-volume, easy-to-administer subcutaneous formulations across multiple different m Abs EXCELSETM: amino acid blends to reduce protein clumping Microglassification ™M: protein microbead process Arestat TM: oligomers of ethyleneimine Camphor sulfonic acid derivatives ENHANZEⓇ: hyaluronidase used to enhance SQ tissue absorption TM Hybrozyme ™M: hyaluronidase variant RaniPill TM: oral capsule drug delivery system 27

View entire presentation